IBB241108C146500
- 1.88
- 0.000.00%
iShares Biotechnology ETF Newsroom
TSLA Up, China Down, Friday Market Quiet After Loud, Decisive Week | Live Stock
Mettler-Toledo Shares Are Trading Lower. The Company Reported Q3 Financial Results.
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday as Investors Step Back From Frenzied Trading Week
Amgen, AstraZeneca Post Phase 3 Win for Nasal Polyps Therapy
Mettler-Toledo Non-GAAP EPS of $10.21 Beats by $0.20, Revenue of $954.54M Beats by $10.13M
FOMC Cut Sends Prices Up, Election Blitz Strong | Wall Street Today
Coherus Stock Rallies 19% on Q3 Earnings, Udenyca Production Update
Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?
Market Hits All-Time Highs on FOMC Rate Day | Live Stock
Sector Update: Health Care Stocks Advance Premarket Thursday
Gilead Sciences Announces Late-Breaking Clinical Data And Real-World Evidence To Be Presented At HIV Glasgow As Co Extends Leadership Efforts Toward Ending The Epidemic
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday Ahead of FOMC Meeting Announcement
Gilead Sciences Analyst Ratings
Gilead Sciences Declares $0.77 Dividend
Gilead Sciences, Inc. (GILD) Q3 2024 Earnings Call Transcript Summary
Gilead Sciences in Charts: Revenue From Major Products Rises Y/Y in Q3
Gilead Rises as It Raises 2024 Sales, Non-GAAP EPS Outlook
Mettler-Toledo Q3 2024 Earnings Preview
Market Prices in Trump Victory with Index Records | Wall Street Today
Gilead Sciences Non-GAAP EPS of $2.02 Beats by $0.47, Revenue of $7.55B Beats by $550M